low density lipoprotein inhibitor

09/01/1999 - "In conclusion, hypercholesterolemia can be due to particle-related slow clearance of LDL in some patients. "
01/01/2015 - "[Association between food behavior and hypercholesterolemia-LDL in university students]."
03/01/2014 - "LDLR deficiency, hypercholesterolemia and elevated plasma LDL in NS are associated with upregulation of PCSK9 and IDOL. "
04/01/2013 - "Hypercholesterolemia was diagnosed in 120 (22.3%; 95% CI 18.6-26.7), decreased HDL in 22 (4.1%; 95% CI 2.7-6.2), high LDL in 79 (14.7%; 95% CI 11.8-18.3), and high TG in 96 (17.8%, 95% CI 14.7-21.9) subjects. "
06/01/2002 - "Despite the relatively high percentage of patients reaching goal LDL in the primary care group, referral to clinical pharmacy specialists resulted in statistically significant increases in the number of patients appropriately treated for hypercholesterolemia and achieving goal LDL."

06/01/2004 - "Further studies are required to define the role of LDL(-) in atherogenesis more precisely and to clarify mechanisms involved in endothelial cell activation."
02/01/2001 - "Familial hypercholesterolaemia (FH) is a powerful clinical model in which to study the predictive role of LDL in atherogenesis. "
09/30/2000 - "We have conducted this study in order to investigate the possible influence of this kind of diet on the oxidation of LDL in vitro, the key element for the development of atherosclerosis. "
09/01/1991 - "This study suggests that the modulation of gap-junctional communication by the balance of HDL and LDL in plasma may influence atherogenesis."
11/06/2015 - "Altered Metabolism of LDL in the Arterial Wall Precedes Atherosclerosis Regression."

08/01/2015 - "IMPROVE-IT and genetics reaffirm the causal role of LDL in Cardiovascular Disease."
09/01/2011 - "A relatively greater and positive correlation between greater levels of RLP-C and SAA-LDL in obese subjects with MetS, in comparison with those without MetS, may be linked to the development of MetS-related cardiovascular disease."
02/12/2005 - "[Role of LDL in cardiovascular diseases. "
01/01/2002 - "Comparison of LDL fatty acid and carotenoid concentrations and oxidative resistance of LDL in volunteers from countries with different rates of cardiovascular disease."
10/01/2000 - "High levels of small, dense LDL in plasma are associated with increased risk for cardiovascular disease. "

09/01/2015 - "Blood lipid changes in the study results showed that there was no significant difference in TC, TG, and LDL in both groups; however, there was a significant interaction between the composite weight-loss dietary supplement intake and HDL-C as well as an increase in the HDL-C of DG. "
09/01/2005 - "Weight loss associated with reduced intake of carbohydrate reduces the atherogenicity of LDL in premenopausal women."
02/01/1985 - "To determine the mechanisms regulating plasma LDL levels, we used 131I-VLDL and 125I-LDL to measure the fractional catabolic rates (FCR), production rates (PR), and rates of interconversion of apoprotein B (apo B) in VLDL, intermediate density lipoprotein, and LDL in six hypertriglyceridemic subjects pre- and post-weight reduction. "
01/01/2010 - "The current study was designed to test the efficacy of auricular acupressure on weight reduction and serum total cholesterol (TC), total triglycerides (TG), high density lipids (HDL) and low density lipids (LDL) in an eight-week, randomized controlled trial of three groups of 84 adolescents aged 18-20 with a body mass index (BMI) of 23 or higher. "
02/01/1987 - "Changes in LDL in EAE might be related in part to lowered plasma very low density lipoproteins (VLDL); however, weight loss in control animals did not increase plasma cholesterol or apoE relative to apoA-I. Lesions in the central nervous system and/or activation of macrophages might be causally related to the large increase in plasma apoE. "

07/01/1999 - "Lipopheresis is a safe and effective method for the control of LDL in nephrotic syndrome. "
01/01/1995 - "To distinguish between these possibilities, we assessed the effects of HMG-CoA reductase inhibitors in another condition in which there is both apoB overproduction and accumulation of VLDL and LDL in plasma, the nephrotic syndrome. "
01/01/1988 - "Using monospecific antibodies to purified human apolipoproteins, immunofluorescence microscopy of renal biopsies from 4 patients with nephrotic syndrome revealed apolipoprotein (apo) AI, apo CIII and apo B (LDL) in lysosomes of the proximal tubular cells. "
01/01/2014 - "To investigate the effect of the HMG-CoA reductase inhibitor lovastatin on the expression of the receptor for hepatic low-density lipoprotein (LDL) in a rat model with kidney disease, and to identify the mechanisms in statin treatment of nephrotic syndrome with hyperlipidemia, a rat model with nephrotic syndrome was established. "
07/01/2002 - "We investigated, for the first time in humans, the enhanced induction of LDL oxidation in chronic glomerulonephritis, the presence of circulating antibodies against oxidatively-modified LDL in patients with IgA glomerulonephritis (IgA GN) or with nephrotic syndrome associated with focal glomerulosclerosis (FGS) and primary membranous glomerulonephritis (MGN). "